cycloheximide has been researched along with Parkinsonian Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greene, LA; Jackson-Lewis, V; Jin, ZH; Malagelada, C; Przedborski, S | 1 |
| Dawson, TM; Dawson, VL; Moore, DJ; Zhang, L | 1 |
2 other study(ies) available for cycloheximide and Parkinsonian Disorders
| Article | Year |
|---|---|
Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Cell Death; Cycloheximide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Gene Expression Regulation; Green Fluorescent Proteins; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Nerve Growth Factor; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; PC12 Cells; Protein Serine-Threonine Kinases; Rats; Serine; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Transcription Factors; Transfection; Tyrosine 3-Monooxygenase | 2010 |
A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization.
Topics: Autoantigens; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cycloheximide; Electrophoresis, Gel, Pulsed-Field; Humans; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Leucine; Methionine; Mutation, Missense; Oncogene Proteins; Parkinsonian Disorders; Phenylalanine; Precipitin Tests; Protein Deglycase DJ-1; Protein Synthesis Inhibitors; Proteins; Proto-Oncogene Proteins c-myc; Ribonucleoproteins; RNA, Messenger; SS-B Antigen; Sulfur Isotopes; Transfection | 2003 |